iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targetingKristin M. Snyder, Bruce Walcheck, Anders W. Matson et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphomaKate Dixon, Bruce Walcheck, Kristin M. Snyder et al.|Frontiers in Immunology|2024Cited by 7
Arming of iPSC-Derived NK Cells Expressing a Novel CD64 Fusion Receptor with Therapeutic Antibodies Represents a Novel Off-the-Shelf, Antigen-Targeting Strategy for CancerKate Dixon, Bruce Walcheck, Kristin M. Snyder et al.|Blood|2021Cited by 0